Insulin-producing cells found in a variety of tissues in diabetes

February 17, 2004

HOUSTON -- (Feb. 17, 2004) -- Cells that produce insulin have been unexpectedly found in the fat, liver and bone marrow of diabetic mice, said researchers at Baylor College of Medicine (BCM) in a report that appeared today in the Proceedings of the National Academy of Sciences.

"In fact, the appearance of insulin-producing cells occurs in both type 1 (juvenile) and type 2 (adult-onset) diabetic mice," said Dr. Lawrence Chan, chief of the BCM endocrinology section and professor in the department of medicine and molecular and cellular biology.

"The common denominator in all the animals is high blood sugar, not insulin-deficiency," he said. "High blood sugar causes these cells to produce insulin."

The numbers of cells and the amount of insulin produced are both very small and do not seem to ameliorate the animals' disease, said Chan.

He found that the source of the insulin-producing cells is the bone marrow, which had been identified as the origin of many different kinds of tissues in recent years. He and his colleagues were surprised that only a brief three-day period of high blood glucose was sufficient to nudge the cells outside the pancreas to produce insulin.

If this inherent property of cells can be harnessed and augmented, Chan speculates, scientists could it to generate insulin-producing cells from other tissues for the treatment of diabetes. If the production of insulin by cells outside the pancreas affects the immune system, which goes awry in people predisposed to type 1 diabetes, it could affect the course of the disease.
-end-
Anissa Anderson Orr
713-798-4712
anissaa@bcm.tmc.edu
www.bcm.tmc.edu/pa


Baylor College of Medicine

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.